Design for Usability - Diabetes Self-Care System

**需求**到2045年，全球将有超过7.8亿人被告知患有糖尿病。与这些预测相关的医疗成本令人瞠目结舌；到2030年，全球将达到2.5万亿英镑。据英国糖尿病协会称，英国约有500万人患有糖尿病，另有50万人未确诊。2014年，NHS的成本估计为100亿英镑（占NHS预算的10%）。到2034年，这些数字将急剧增加，每年有700万人的诊断和护理费用达到176亿英镑（占NHS预算的17%）。这是不可持续的，需要实施由创新诊断技术支持的激进的新护理战略，以帮助减轻这些预测的直接和外围影响。**问题** 40多年来，通过提供越来越精确的测量系统，血糖水平的自测已被纳入临床实践。然而，2型糖尿病患者每天测量3次血糖水平的治疗价值目前存在争议。这相当于监测原因，而不是评估结果，而就病人的治疗结果和提供护理的成本而言，结果才是重要的。需要对糖尿病护理进行彻底的重新定位，并且必须将能够实现这一目标的新技术引入网络，以支持向更可持续的战略过渡。**解决方案** NHS长期计划旨在通过提供数字自我管理支持工具来改善护理。IDF指出，疾病管理和治疗依从性不足是问题的根源，并表示迫切需要创新的方法。ADA建议增加对糖化血红蛋白（HbA1c）的监测，用于糖尿病的诊断和管理。然而，目前还没有类似于SMBG系统的测量HbA1c和BG水平的设备。糖尿病护理顾问本·菲尔德（Ben Field）博士说：“在一个用户友好、信息丰富的设备上进行准确的糖化血红蛋白自我检测，将被证明是非常强大的。”他的一位高级助理告诉我们：“将10%的2型糖尿病患者转移到基于HbA1c自我检测的护理计划将会改变游戏规则。”有了正确的治疗策略和强有力的患者参与，2型糖尿病患者有可能回到非糖尿病状态。SmartCare系统提供了一种新方法的技术，当它被主要竞争对手之一推出时，它将彻底改变糖尿病护理策略并改善患者的健康。

**The Need**By 2045 over 780 million people around the world will have been told they have diabetes. The costs of healthcare associated with these predictions are eyewatering; £2.5trillion worldwide by 2030\.According to Diabetes UK there are circa 5million people in the UK living with diabetes, and a further 500,000 undiagnosed.The cost to the NHS was estimated at £10billion in 2014 (10% of NHS budget). These figures are set to increase dramatically by 2034, with 7million diagnosed and care costs at £17.6billion annually (17% of NHS budget).This is not sustainable and demands the implementation of radical new care strategies supported by innovative diagnostic technology that help mitigate the immediate and peripheral impacts of these predictions.**The Problem**For 40+ years self-testing of blood glucose levels has been integrated in clinical practice through the provision of increasingly accurate measurement systems. However, the therapeutic value of type 2 diabetics measuring their blood glucose level 3x daily is now disputed. It amounts to monitoring the cause rather than assessing the effect, when it is the effect that matters in terms of patient outcomes and the cost of care provision.A radical repositioning of diabetes care is required and new technology that enables this to happen must be brought online to support the transition to more sustainable strategies.**The Solution**The NHS Long Term Plan aims to improve care through the provision of digital self-management support tools.The IDF points to inadequate disease management and therapy adherence as the root of the problem, and says innovative approaches are urgently required.The ADA recommends increasing the monitoring of glycosylated haemoglobin (HbA1c) for diabetes diagnosis and management.However, there are currently no devices that measure the HbA1c and BG levels using the same procedure as SMBG systems.Dr Ben Field, Consultant in Diabetes Care, says "accurate HbA1c self-testing, in a user-friendly, informative device, would prove to be very powerful".A senior associate of his told us: "Shifting 10% of the type 2 diabetic population onto a self-test HbA1c based care program would be game-changing".With the right therapeutic strategy and strong patient engagement, it is possible for people with type 2 diabetes to follow a path back to a non-diabetic state.The SmartCare system provides the technology that enables a new approach and when it is launched by one of the main competitors it will revolutionise diabetes care strategy and improve patient wellbeing.